CHICAGO – Researchers from Penn Medicine’s Abramson Cancer Center (ACC) and the Perelman School of Medicine at the University of Pennsylvania will present data on the latest advances in cancer research at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting , happening May 31—June 4, 2024 in Chicago and online. Follow @PennMedicine and @PennMDForum for updates.
Experts from Penn Medicine are available to comment on a wide range of cancer research and care topics before, during, and after the meeting by video call, phone, or email. To arrange interviews, please contact Meagan Raeke at Meagan.Raeke@pennmedicine.upenn.edu or 267-693-6224.
Lynn M. Schuchter, MD, FASCO , the Madlyn and Leonard Abramson Professor of Clinical Oncology and director of the Tara Miller Melanoma Center , is the 2023-2024 ASCO President, and the ASCO Annual Meeting program features more than 200 sessions complementing her Presidential Theme: The Art and Science of Cancer Care: From Comfort to Cure . Schuchter’s experiences treating patients over a three-decade career at Penn informed the development of her patient-centered theme for the meeting.
In addition, Angela DeMichele, MD, MSCE, FASCO , the Mariann T. and Robert J. MacDonald Professor in Breast Cancer Research, is the chair of the Scientific Program Committee; Charu Aggarwal, MD, MPH, FASCO , the Leslye M. Heisler Associate Professor for Lung Cancer Excellence, is the chair of the Cancer Communications Committee and an incoming elected member of the Nominating Committee; and Neha Vapiwala, MD , FASCO , a professor of Radiation Oncology, is an elected member of the Nominating Committee.
Check back for additional news releases during the meeting .
Penn researchers will present results from clinical trials, including a national cooperative group study for esophageal cancer , a Phase I study using a new CAR T cell therapy for re-treatment in patients with lymphoma , and a multicenter study of a combination therapy for ovarian cancer . They will also present results from several studies that show how AI is being applied to cancer care.
Treatment clinical trials
AI in cancer care
###
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine , founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.